Literature DB >> 18820829

A case of lymphangioleiomyomatosis with membranous nephropathy and likely systemic lupus.

Ramin Sam1,2, Samra Khalid3, Carolyn Brecklin4,5, Melvin Schwartz6, George Dunea4,7.   

Abstract

Membranous glomerulonephritis is most often idiopathic, but it can be secondary to systemic lupus erythematosus, viral hepatitis, and drugs. A number of malignancies have also been associated with membranous glomerulonephritis, although a causal link has not been established yet. A young patient with lymphangioleiomyomatosis is described who developed massive proteinuria and was found to have membranous glomerulonephritis on renal biopsy. There were many pathological features and some clinical features that suggested the patient also suffered from systemic lupus erythematosus.

Entities:  

Mesh:

Year:  2008        PMID: 18820829     DOI: 10.1007/s10157-008-0083-0

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  16 in total

Review 1.  Rare diseases. 1. Lymphangioleiomyomatosis: clinical features, management and basic mechanisms.

Authors:  S Johnson
Journal:  Thorax       Date:  1999-03       Impact factor: 9.139

2.  Lymphangioleiomyomatosis. Clinical course in 32 patients.

Authors:  J R Taylor; J Ryu; T V Colby; T A Raffin
Journal:  N Engl J Med       Date:  1990-11-01       Impact factor: 91.245

Review 3.  The tuberous sclerosis complex.

Authors:  Peter B Crino; Katherine L Nathanson; Elizabeth Petri Henske
Journal:  N Engl J Med       Date:  2006-09-28       Impact factor: 91.245

4.  Extrathoracic angiomyolipomas in lymphangioleiomyomatosis.

Authors:  D E Maziak; S Kesten; D C Rappaport; J Maurer
Journal:  Eur Respir J       Date:  1996-03       Impact factor: 16.671

5.  Carcinoembryonic antigen-antibody complexes in a patient with colonic carcinoma and nephrotic syndrome.

Authors:  M E Costanza; V Pinn; R S Schwartz; L Nathanson
Journal:  N Engl J Med       Date:  1973-09-06       Impact factor: 91.245

6.  Comprehensive evaluation of 35 patients with lymphangioleiomyomatosis.

Authors:  S C Chu; K Horiba; J Usuki; N A Avila; C C Chen; W D Travis; V J Ferrans; J Moss
Journal:  Chest       Date:  1999-04       Impact factor: 9.410

Review 7.  Renal angiomyolipoma in association with pulmonary lymphangioleiomyomatosis.

Authors:  Rebecca A De Pauw; Johan R Boelaert; Christel W Haenebalcke; Erve G Matthys; Mario S Schurgers; An S De Vriese
Journal:  Am J Kidney Dis       Date:  2003-04       Impact factor: 8.860

8.  Distribution of IgG subclasses in membranous nephropathy.

Authors:  T Doi; M Mayumi; K Kanatsu; F Suehiro; Y Hamashima
Journal:  Clin Exp Immunol       Date:  1984-10       Impact factor: 4.330

9.  Differential characteristics of immune-bound antibodies in diffuse proliferative and membranous forms of lupus glomerulonephritis.

Authors:  J L Roberts; R J Wyatt; M M Schwartz; E J Lewis
Journal:  Clin Immunol Immunopathol       Date:  1983-11

10.  IgG subclass deposits in glomeruli of lupus and nonlupus membranous nephropathies.

Authors:  M Haas
Journal:  Am J Kidney Dis       Date:  1994-03       Impact factor: 8.860

View more
  1 in total

Review 1.  Cell type-specific mechanistic target of rapamycin-dependent distortion of autophagy pathways in lupus nephritis.

Authors:  Tiffany Caza; Chathura Wijewardena; Laith Al-Rabadi; Andras Perl
Journal:  Transl Res       Date:  2022-03-12       Impact factor: 10.171

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.